This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Allergy Immunotherapy Market

Market Insights on Allergy Immunotherapy covering sales outlook, demand forecast & up-to-date key trends

Allergy Immunotherapy Market by Product (SLIT Tablets, Oral, Injections), Immunotherapy (Sublingual Immunotherapy, Subcutaneous Immunotherapy), Indication, Allergen, Distribution Channel & Region - Forecast to 2020-2030

Introduction

Allergy immunotherapy is a treatment to prevent allergic reactions caused by food, grass pollen, dust, and bee venom among other causes. Allergy immunotherapy aids in controlling symptoms among people suffering from allergies such as rhinitis, asthma, and conjunctivitis, among other common allergies.

Allergy immunotherapy involves injections on a regular basis that generally increase the dosage to develop the resistance in the patient. With a progressive increase in dosage, the patient's immunity system becomes less fragile due to the increased production of blocking antibodies that fight the foreign substances that cause allergies.

At present, there are three main types of allergy immunotherapy products in use, namely sublingual allergy immunotherapy (SLIT), subcutaneous allergy immunotherapy (SCIT)/injection, and oral allergy immunotherapy. Among these, SLIT offers treatment without injections, instead treating the allergies with tablets.

Tablets used in the SLIT treatment are used to treat allergies caused by ragweed, grass pollen, and dust mites, and are approved by the US Food and Drugs Administration (FDA). However, SLIT offers treatment for only one type of allergen and does not prevent curbing the possibility of developing other kinds of allergies.

This gives an edge to SCIT treatment, which is considered the most effective form of allergy immunotherapy since it simultaneously prevents the development of asthma and other allergies. As people across the world grow highly sensitive to different types of allergies, the proliferating need for effective fighting methodologies will drive the market on a positive growth trajectory.

Customize this Report

Let us know your requirement to get
100% FREE customization

Increasing Incidence of Allergies Calls for Efficient Treatments

The rising prevalence of allergies year-on-year worldwide is propelling demand for effectual allergy immunotherapy. For instance, allergic rhinitis is among one of the most common allergies in the world, affecting roughly 10% to 30% of the global population.

According to the estimates of the American Academy of Allergy Asthma & Immunology, nearly 7.8% of the American population aged above 18 develop allergic rhinitis.

Likewise, in 2012, over 17.6 Mn adults and 6.6 Mn children were reported to be diagnosed with rhinitis. The number grew to 20 Mn adults in 2015, thus creating demand for treatments that improve the lifestyle and offer relief from the effects of the allergy.

Along similar lines, other allergies such as asthma, skin allergies, and food allergies, are also quite prevalent across the world and continue to drive demand for immunotherapy.

In 2016, the World Health Organization (WHO) estimated that over 339 people suffer from asthma globally and attributed more than 400,000 deaths to asthma in that year. By the same token, Food Allergy Research & Education (FARE) reported that over 32 Mn people in the US suffer from food allergies, necessitating emergency medical care for one person in every 3 minutes to seek.

Similarly, new research by the Journal of Allergy and Clinical Immunology (JACI) estimated that 2-37% of the European population has a self-reported food allergy. As people become increasingly aware of the availability of these treatments, an increasing number of people are willing to seek treatment, driving the allergy immunotherapy market on a remunerative path.

High Demand for Advanced Procedures

The growing incidence of allergies and the subsequent spending on medical treatments are enabling market players to enhance their treatment offerings. Players are enhancing the existing SLIT drugs, which have proven efficient in treating airway allergies, atopic dermatitis, and a few food allergies.

Recent surveys have suggested that SLIT remains a popular choice among consumers over SCIT, despite its limitations, owing to its accessibility. Moreover, it has been noted that the prevalence of food allergy rises 10% every year, leading to higher demand for immunotherapy for food allergies.

By the same token, oral immunotherapy is gaining prominence among medical professionals and patients, especially in the treatment of allergic rhinitis. Oral immunotherapy is majorly used to control the incidence of allergic reactions caused by accidental or unintentional allergen exposures for individuals with minimal levels of tolerance. On this premise, market players are focusing on improving their offerings on the oral immunotherapy front.

On the other hand, macroeconomic factors such as increasing levels of pollution, changing eating habits, and increased consumption of alcohol are resulting in increased prevalence of skin and other allergies, further boosting the need for allergy immunotherapy.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Key Challenges: High Cost and Side Effects

Allergy immunotherapy is a longer process than conventional therapies, prolonging for 3 to 5 years based on the type and severity of the allergy. It is likely to instigate patients to discontinue halfway through the treatment, owing to financial constraints during the process. This is expected to pose a challenge to the growth of the market to an extent.

On these lines, it is to be noted that allergy immunotherapy is relatively more expensive than traditional medication therapies due to the lengthy nature. The annual cost of allergy treatment is around $1000, with oral therapy costing $4000, while SLIT going beyond $7000. As a result, patients rely on healthcare insurance to cover their expenses. When not covered under insurance, those who cannot afford the treatment have no other option but to resort to temporary medication. The high cost of the treatment is limiting the adoption, thereby hindering the overall growth.

On the other hand, the side-effects of these treatments are expected to hold back the growth. Approximately 1.5% of patients undergoing oral immunotherapy experience side effects such as respiratory, gastrointestinal, or skin-related disorders, thus further restraining the healthy growth of the market.

Region-wise Analysis

Europe Allergy Immunotherapy Market

Europe is expected to remain the largest regional market for allergy immunotherapy during the assessment period, accounting for more than half of the global market value. The region's dominance is attributed to the presence of a wide population base with various allergies. The European Academy of Allergy and Clinical Immunology (EAACI) reports that over 150 Mn people, representing 20% of the region's population, currently suffer from chronic food allergies.

Allergic rhinitis and asthma have been identified as the most common allergies, affecting 100 Mn and 70 Mn people respectively. Furthermore, the organization reported that by 2025, 50% of Europe’s population will be affected by allergies, thus creating a lucrative growth opportunity for the allergy immunotherapy market.

By the same token, the prevalence of allergies in Europe is also mounting into a huge economic burden, due to consequential productivity losses in European nations. On the back of these factors, European governments and bodies including EAACI are working on raising awareness among people and are calling for better medical education and treatments, thereby positively influencing the growth of the market in the region.

North America Allergy Immunotherapy Market

Although North America holds a relatively lower share than Europe, it will remain the second most lucrative region through the assessment period. The US is poised to remain at the forefront of the North American market, accounting for the majority of market value owing to the high prevalence of allergies in the region.

Allergy Immunotherapy Market Download Report Brochure

As per the estimates of the American College of Allergy, Asthma (ACAAI), allergies are the sixth leading cause of chronic illness in the US, affecting more than 50 million people and resulting in expenses worth more than US$ 18 Bn every year.

Moreover, children are at a higher risk of allergies. According to the 2014 National Health Interview Survey (NHIS), 8.4% of US children under age 18 suffered from allergic rhinitis, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies.

Due to the aforementioned facets, the demand for allergy immunotherapy will prevail high for the years to come.

East Asia is projected to remain a prominent region for the global allergy

East Asia Allergy Immunotherapy Market

immunotherapy market, backed by the presence of a vast population base in China, Japan, and South Korea suffering from various kinds of allergies. Allergic rhinitis is one of the most common allergies in China and has significantly increased in the previous two decades.

Similarly, according to the Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI), oral immunotherapy is gaining tremendous traction in the region owing to the convenience associated with it, especially among patients suffering from allergic rhinitis. These factors will continue to drive the market on a positive growth trajectory through the assessment period.

Category-wise Insights

Injection Remains Most Sought-out

Based on the product type, the injection segment is poised to remain the most sought out product type, accounting for nearly 2/3rd of market share through the forecast period. This is essentially attributed to higher effectiveness and quicker response to the medication.

SCIT Holds Lion's Share

By immunotherapy type, the SCIT segment is anticipated to account for the majority of market share, accounting for 2/3rd of share in global value. The high preference for injections is majorly attributed to high effectiveness and ability to treat multiple allergies, which gives it an edge over its counterpart, SLIT immunotherapy.

Allergic Rhinitis Creates Huge Demand

On the basis of indication, allergic rhinitis is forecasted to capture more than 2/5h of global market value, being one of the most common allergies worldwide. On the other hand, allergic asthma is expected to channel more than 1/5th of market share, owing to the high prevalence among children.

Pollens and House Dust Mites Remain Most Common

Among allergens, pollens and house dust mites are expected to cumulatively account for more than 2/5th of market share, holding a share of near-equal proportions. This is ascribed to the fact that they are highly common in living areas, thus easily affecting people across the world.

Institutional Sales Hold Dominance

By distribution channel, institutional sales are expected to channel the majority of revenue, due to high reliance on government and semi-government hospitals for treatments backed by their affordability. This is also attributed to the availability of reimbursements and supportive policies in government hospitals in developed economies.

Competitive Landscape

Market players are leveraging the growing prevalence of allergies and are directing their efforts towards developing treatments for food allergies, in specific. To achieve the same, they are investing in research and development activities. On these lines, Aimmune Therapeutics (Nestle Health Science) became the first organization to procure FDA approval for its drug named PALFORZIA to treat food allergies, after receiving approval in 2020.

Several organizations are focusing on developing new products - both tablets and injections to stay ahead of the curve. On this premise, in April 2020, ALK Abello announced that Health Canada has approved once-daily ITULATEK, a sublingual tablet for the treatment of tree pollen allergy.

On the other hand, growing demand is compelling market players to expand their supply capacity, which has also been observed as a key trend. On this premise, In May 2020, Stallergenes Greer announced the expansion of the supply of subcutaneous products (SCIT), to cater to the growing demand.

Some of the leading players in the market are:

  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies

This list is only indicative – The full list of allergy immunotherapy market players is available on request.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Allergy Immunotherapy Market Report: Scope

Attribute

Details

Forecast Period

2020-2030

Historical Data Available for

2015-2019

Market Analysis

USD Million for value and units for volume

Key Regions Covered

North America, Europe, East Asia, Latin America, South Asia, Oceania, and Middle East and Africa (MEA)

Key Countries Covered

US, Canada, Brazil, Mexico, Rest of Latin America, Germany, Italy, France, Spain, U.K., Russia, Rest of Europe, China, Japan, South Korea, India, Malaysia, Thailand, Indonesia, Australia, New Zealand, South Africa, and Rest of MEA

Key Segments Covered

Product, Immunotherapy, Distribution Channel, Allergen, Indication, and Region

Key Companies Profiled

ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies, and others.

Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Allergy Immunotherapy Market - Segmentation

Product:

  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
    • Others
  • Injections
  • Others

Immunotherapy:

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
    • Specific Immunotherapy
  • Others

Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergen:

  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
  • House Dust Mites
  • Mould
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects
  • Others

Distribution Channel

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • Oceania
  • East Asia
  • Middle East and Africa

Frequently Asked Questions

The global allergy immunotherapy market is expected to reach a valuation of US$ 2,892.2 Mn by 2030.

Europe is expected to maintain hegemony over the regional landscape through the course of the forecast period

Key players operating in the market include ALK Abello (Europe), Stallergenes Greer (Europe), Allergy Therapeutics (Europe), Aimmune Therapeutics (U.S.), Anergis (Europe), Arrayit Corporation (U.S.), Biomay AG (Europe), HAL Allergy Group (Europe), DBV Technologies (Europe), and others.

The institutional sales segment is expected to channel the majority of revenue to the allergy immunotherapy market through the forecast period.

The growth of the allergy immunotherapy market is primarily attributed to the rising prevalence of allergies worldwide.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Market Analysis

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Market Background

    4.1. COVID-19 Crisis Analysis

    4.2. Macro-Economic Factors

        4.2.1. Global GDP Growth Outlook

        4.2.2. Global Healthcare Expenditure Outlook

    4.3. Forecast Factors - Relevance & Impact

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity Analysis

5. Market Context

    5.1. Global Sublingual Allergy Immunotherapy Market Value ($ Mn) Analysis and Forecast 2015–2030, By Product Type

    5.2. Global Sublingual Allergy Immunotherapy Market Value (Mn Units) Analysis and Forecast 2015–2030, By Product Type

    5.3. Global Sublingual Allergy Immunotherapy Market Average Drug Pricing 2019, By Product Type ($)

    5.4. Sublingual Immunotherapy Granular Analysis – Key Promotional Strategies, By Manufacturers

    5.5. Allergy Immunotherapy Market - Product Adoption / Usage Analysis, By Region

    5.6. Allergy Immunotherapy Market – Product(s) Vs Usage Matrix

    5.7. Allergy Immunotherapy Market – Market Participants

    5.8. Allergy Immunotherapy Market - Latest Industry Deals/M&A

    5.9. Allergy Immunotherapy Market – Pipeline Product Analysis

    5.10. Sublingual Allergy Immunotherapy Market – List of Approved Products

    5.11. Allergy Immunotherapy Market – Reimbursement Scenario

    5.12. Allergy Immunotherapy Market – Regulatory Scenario

6. Global Allergy Immunotherapy Market Demand (in Volume) Analysis 2015-2019 and Forecast, 2020-2030

    6.1. Historical Market Volume Analysis, 2015-2019

    6.2. Current and Future Market Volume Projections, 2020-2030

    6.3. Y-o-Y Growth Trend Analysis

7. Global Allergy Immunotherapy Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Drug Class

    7.2. Global Average Pricing Analysis Benchmark

8. Global Allergy Immunotherapy Market Demand (in Value or Size in US$ Mn) Analysis 2015–2019 and Forecast, 2020–2030

    8.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    8.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type , 2015 - 2019

    9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2020 - 2030

        9.3.1. SLIT Tablets

        9.3.2. Oral

        9.3.3. Injections

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Product Type

10. Global Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030, By Immunotherapy Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Immunotherapy Type, 2015 - 2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Immunotherapy Type, 2020 - 2030

        10.3.1. Sublingual Immunotherapy (SLIT)

        10.3.2. Subcutaneous Immunotherapy (SCIT)

            10.3.2.1. Specific Immunotherapy

        10.3.3. Others

    10.4. Market Attractiveness Analysis By Immunotherapy Type

11. Global Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 - 2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020 - 2030

        11.3.1. Allergic Rhinitis

        11.3.2. Allergic Asthma

        11.3.3. Food Allergy

        11.3.4. Atopic Dermatitis

        11.3.5. Others

    11.4. Market Attractiveness Analysis By Indication

12. Global Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030, By Allergan

    12.1. Introduction / Key Findings

    12.2. Current and Historical Market Size (US$ Mn) Analysis By Allergan Type, 2015 - 2019

        12.2.1. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergan Type, 2020 - 2030

        12.2.2. Pollens

        12.2.3. House Dust Mites (HDM)

        12.2.4. Mould

        12.2.5. Animal Dander

        12.2.6. Bee Venom

        12.2.7. Cockroaches/Insects

        12.2.8. Others

    12.3. Market Attractiveness Analysis By Allergan Type

13. Global Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015 - 2019

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020 - 2030

        13.3.1. Institutional Sales

            13.3.1.1. Government Hospitals

            13.3.1.2. Semi-Government Hospitals

            13.3.1.3. Private Hospitals

        13.3.2. Retail Sales

    13.4. Market Attractiveness Analysis By Distribution Channel

14. Global Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. East Asia

        14.3.5. South Asia

        14.3.6. Oceania

        14.3.7. Middle East and Africa

    14.4. Market Attractiveness Analysis By Region

15. North America Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Regional Dynamics

    15.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    15.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        15.4.1. By Country

            15.4.1.1. U.S.

            15.4.1.2. Canada

        15.4.2. By Product Type

        15.4.3. By Immunotherapy Type

        15.4.4. By Indication

        15.4.5. By Allergan Type

        15.4.6. By Distribution Channel

    15.5. Market Attractiveness Analysis

16. Latin America Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Regional Dynamics

    16.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    16.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        16.4.1. By Country

            16.4.1.1. Brazil

            16.4.1.2. Mexico

            16.4.1.3. Rest of Latin America

        16.4.2. By Product Type

        16.4.3. By Immunotherapy Type

        16.4.4. By Indication

        16.4.5. By Allergan Type

        16.4.6. By Distribution Channel

    16.5. Market Attractiveness Analysis

17. Europe Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Regional Dynamics

    17.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    17.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        17.4.1. By Country

            17.4.1.1. Germany

            17.4.1.2. Italy

            17.4.1.3. France

            17.4.1.4. U.K.

            17.4.1.5. Spain

            17.4.1.6. Russia

            17.4.1.7. Rest of Europe

        17.4.2. By Product Type

        17.4.3. By Immunotherapy Type

        17.4.4. By Indication

        17.4.5. By Allergan Type

        17.4.6. By Distribution Channel

    17.5. Market Attractiveness Analysis

18. East Asia Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Regional Dynamics

    18.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    18.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Product Type

        18.4.3. By Immunotherapy Type

        18.4.4. By Indication

        18.4.5. By Allergan Type

        18.4.6. By Distribution Channel

    18.5. Market Attractiveness Analysis

19. South Asia Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Regional Dynamics

    19.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    19.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        19.4.1. By Country

            19.4.1.1. India

            19.4.1.2. Malaysia

            19.4.1.3. Indonesia

            19.4.1.4. Thailand

            19.4.1.5. Rest of South Asia

        19.4.2. By Product Type

        19.4.3. By Immunotherapy Type

        19.4.4. By Indication

        19.4.5. By Allergan Type

        19.4.6. By Distribution Channel

    19.5. Market Attractiveness Analysis

20. Oceania Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

    20.2. Regional Dynamics

    20.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    20.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        20.4.1. By Country

            20.4.1.1. Australia

            20.4.1.2. New Zealand

        20.4.2. By Product Type

        20.4.3. By Immunotherapy Type

        20.4.4. By Indication

        20.4.5. By Allergan Type

        20.4.6. By Distribution Channel

    20.5. Market Attractiveness Analysis

21. Middle East and Africa Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    21.1. Introduction

    21.2. Regional Dynamics

    21.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    21.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        21.4.1. By Country

            21.4.1.1. GCC Countries

            21.4.1.2. South Africa

            21.4.1.3. Rest of Middle East and Africa

        21.4.2. By Product Type

        21.4.3. By Immunotherapy Type

        21.4.4. By Indication

        21.4.5. By Allergan Type

        21.4.6. By Distribution Channel

    21.5. Market Attractiveness Analysis

22. Key and Emerging Countries Allergy Immunotherapy Market Analysis 2015-2019 and Forecast 2020-2030

    22.1. U.S. Allergy Immunotherapy Market Analysis

        22.1.1. By Product Type

        22.1.2. By Immunotherapy Type

        22.1.3. By Indication

        22.1.4. By Allergan Type

        22.1.5. By Distribution Channel

    22.2. Canada Allergy Immunotherapy Market Analysis

        22.2.1. By Product Type

        22.2.2. By Immunotherapy Type

        22.2.3. By Indication

        22.2.4. By Allergan Type

        22.2.5. By Distribution Channel

    22.3. Mexico Allergy Immunotherapy Market Analysis

        22.3.1. By Product Type

        22.3.2. By Immunotherapy Type

        22.3.3. By Indication

        22.3.4. By Allergan Type

        22.3.5. By Distribution Channel

    22.4. Brazil Allergy Immunotherapy Market Analysis

        22.4.1. By Product Type

        22.4.2. By Immunotherapy Type

        22.4.3. By Indication

        22.4.4. By Allergan Type

        22.4.5. By Distribution Channel

    22.5. Argentina Allergy Immunotherapy Market Analysis

        22.5.1. By Product Type

        22.5.2. By Immunotherapy Type

        22.5.3. By Indication

        22.5.4. By Allergan Type

        22.5.5. By Distribution Channel

    22.6. U.K. Allergy Immunotherapy Market Analysis

        22.6.1. By Product Type

        22.6.2. By Immunotherapy Type

        22.6.3. By Indication

        22.6.4. By Allergan Type

        22.6.5. By Distribution Channel

    22.7. Germany Allergy Immunotherapy Market Analysis

        22.7.1. By Product Type

        22.7.2. By Immunotherapy Type

        22.7.3. By Indication

        22.7.4. By Allergan Type

        22.7.5. By Distribution Channel

    22.8. France Allergy Immunotherapy Market Analysis

        22.8.1. By Product Type

        22.8.2. By Immunotherapy Type

        22.8.3. By Indication

        22.8.4. By Allergan Type

        22.8.5. By Distribution Channel

    22.9. Italy Allergy Immunotherapy Market Analysis

        22.9.1. By Product Type

        22.9.2. By Immunotherapy Type

        22.9.3. By Indication

        22.9.4. By Allergan Type

        22.9.5. By Distribution Channel

    22.10. Spain Allergy Immunotherapy Market Analysis

        22.10.1. By Product Type

        22.10.2. By Immunotherapy Type

        22.10.3. By Indication

        22.10.4. By Allergan Type

        22.10.5. By Distribution Channel

    22.11. Benelux Allergy Immunotherapy Market Analysis

        22.11.1. By Product Type

        22.11.2. By Immunotherapy Type

        22.11.3. By Indication

        22.11.4. By Allergan Type

        22.11.5. By Distribution Channel

    22.12. Russia Allergy Immunotherapy Market Analysis

        22.12.1. By Product Type

        22.12.2. By Immunotherapy Type

        22.12.3. By Indication

        22.12.4. By Allergan Type

        22.12.5. By Distribution Channel

    22.13. China Allergy Immunotherapy Market Analysis

        22.13.1. By Product Type

        22.13.2. By Immunotherapy Type

        22.13.3. By Indication

        22.13.4. By Allergan Type

        22.13.5. By Distribution Channel

    22.14. Japan Allergy Immunotherapy Market Analysis

        22.14.1. By Product Type

        22.14.2. By Immunotherapy Type

        22.14.3. By Indication

        22.14.4. By Allergan Type

        22.14.5. By Distribution Channel

    22.15. South Korea Allergy Immunotherapy Market Analysis

        22.15.1. By Product Type

        22.15.2. By Immunotherapy Type

        22.15.3. By Indication

        22.15.4. By Allergan Type

        22.15.5. By Distribution Channel

    22.16. India Allergy Immunotherapy Market Analysis

        22.16.1. By Product Type

        22.16.2. By Immunotherapy Type

        22.16.3. By Indication

        22.16.4. By Allergan Type

        22.16.5. By Distribution Channel

    22.17. ASEAN Allergy Immunotherapy Market Analysis

        22.17.1. By Product Type

        22.17.2. By Immunotherapy Type

        22.17.3. By Indication

        22.17.4. By Allergan Type

        22.17.5. By Distribution Channel

    22.18. Australia Allergy Immunotherapy Market Analysis

        22.18.1. By Product Type

        22.18.2. By Immunotherapy Type

        22.18.3. By Indication

        22.18.4. By Allergan Type

        22.18.5. By Distribution Channel

    22.19. New Zealand Allergy Immunotherapy Market Analysis

        22.19.1. By Product Type

        22.19.2. By Immunotherapy Type

        22.19.3. By Indication

        22.19.4. By Allergan Type

        22.19.5. By Distribution Channel

    22.20. GCC Countries Allergy Immunotherapy Market Analysis

        22.20.1. By Product Type

        22.20.2. By Immunotherapy Type

        22.20.3. By Indication

        22.20.4. By Allergan Type

        22.20.5. By Distribution Channel

    22.21. Turkey Allergy Immunotherapy Market Analysis

        22.21.1. By Product Type

        22.21.2. By Immunotherapy Type

        22.21.3. By Indication

        22.21.4. By Allergan Type

        22.21.5. By Distribution Channel

    22.22. South Africa Allergy Immunotherapy Market Analysis

        22.22.1. By Product Type

        22.22.2. By Immunotherapy Type

        22.22.3. By Indication

        22.22.4. By Allergan Type

        22.22.5. By Distribution Channel

23. Market Structure Analysis

    23.1. Market Analysis by Tier of Companies

    23.2. Market Share Analysis of Top Players

    23.3. Market Concentration

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Competition Deep Dive

        24.2.1. ALK Abello

            24.2.1.1. Overview

            24.2.1.2. Product Portfolio

            24.2.1.3. Sales Footprint

            24.2.1.4. Key Developments

            24.2.1.5. Revenue Distribution, 2019

            24.2.1.6. Revenue Growth

            24.2.1.7. Strategic Overview

            24.2.1.8. Qualitative & Quantitative Product Analysis

            24.2.1.9. Product Pipeline Analysis

            24.2.1.10. Analyst commentary

        24.2.2. Stallergenes Greer

            24.2.2.1. Overview

            24.2.2.2. Product Portfolio

            24.2.2.3. Sales Footprint

            24.2.2.4. Key Developments

            24.2.2.5. Revenue Distribution, 2019

            24.2.2.6. Revenue Growth

            24.2.2.7. Strategic Overview

            24.2.2.8. Qualitative & Quantitative Product Analysis

            24.2.2.9. Product Pipeline Analysis

            24.2.2.10. Analyst commentary

        24.2.3. Allergy Therapeutics

            24.2.3.1. Overview

            24.2.3.2. Product Portfolio

            24.2.3.3. Sales Footprint

            24.2.3.4. Key Developments

            24.2.3.5. Revenue Distribution, 2019

            24.2.3.6. Revenue Growth

            24.2.3.7. Strategic Overview

            24.2.3.8. Qualitative & Quantitative Product Analysis

            24.2.3.9. Product Pipeline Analysis

            24.2.3.10. Analyst commentary

        24.2.4. Aimmune Therapeutics

            24.2.4.1. Overview

            24.2.4.2. Product Portfolio

            24.2.4.3. Sales Footprint

            24.2.4.4. Key Developments

            24.2.4.5. Revenue Distribution, 2019

            24.2.4.6. Revenue Growth

            24.2.4.7. Strategic Overview

            24.2.4.8. Qualitative & Quantitative Product Analysis

            24.2.4.9. Product Pipeline Analysis

            24.2.4.10. Analyst commentary

        24.2.5. Anergis

            24.2.5.1. Overview

            24.2.5.2. Product Portfolio

            24.2.5.3. Sales Footprint

            24.2.5.4. Key Developments

            24.2.5.5. Revenue Distribution, 2019

            24.2.5.6. Revenue Growth

            24.2.5.7. Strategic Overview

            24.2.5.8. Qualitative & Quantitative Product Analysis

            24.2.5.9. Product Pipeline Analysis

            24.2.5.10. Analyst commentary

        24.2.6. Arrayit Corporation

            24.2.6.1. Overview

            24.2.6.2. Product Portfolio

            24.2.6.3. Sales Footprint

            24.2.6.4. Key Developments

            24.2.6.5. Revenue Distribution, 2019

            24.2.6.6. Revenue Growth

            24.2.6.7. Strategic Overview

            24.2.6.8. Qualitative & Quantitative Product Analysis

            24.2.6.9. Product Pipeline Analysis

            24.2.6.10. Analyst commentary

        24.2.7. Biomay AG

            24.2.7.1. Overview

            24.2.7.2. Product Portfolio

            24.2.7.3. Sales Footprint

            24.2.7.4. Key Developments

            24.2.7.5. Revenue Distribution, 2019

            24.2.7.6. Revenue Growth

            24.2.7.7. Strategic Overview

            24.2.7.8. Qualitative & Quantitative Product Analysis

            24.2.7.9. Product Pipeline Analysis

            24.2.7.10. Analyst commentary

        24.2.8. HAL Allergy Group

            24.2.8.1. Overview

            24.2.8.2. Product Portfolio

            24.2.8.3. Sales Footprint

            24.2.8.4. Key Developments

            24.2.8.5. Revenue Distribution, 2019

            24.2.8.6. Revenue Growth

            24.2.8.7. Strategic Overview

            24.2.8.8. Qualitative & Quantitative Product Analysis

            24.2.8.9. Product Pipeline Analysis

            24.2.8.10. Analyst commentary

        24.2.9. DBV Technologies

            24.2.9.1. Overview

            24.2.9.2. Product Portfolio

            24.2.9.3. Sales Footprint

            24.2.9.4. Key Developments

            24.2.9.5. Revenue Distribution, 2019

            24.2.9.6. Revenue Growth

            24.2.9.7. Strategic Overview

            24.2.9.8. Qualitative & Quantitative Product Analysis

            24.2.9.9. Product Pipeline Analysis

            24.2.9.10. Analyst commentary

25. Assumptions and Acronyms Used

26. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 02: Global Sublingual Allergy Immunotherapy Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 03: Global Allergy Immunotherapy Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 03: Global Allergy Immunotherapy Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 04: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 04: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 05: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 06: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 07: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 08: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 09: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 10: Global Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 11: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 12: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 12: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 13: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 14: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 15: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 16: North America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 17: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 18: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 19: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 20: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 21: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 22: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 23: Latin America Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 24: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 25: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 26: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 27: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 28: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 29: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 30: Europe Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 31: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 32: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 33: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 34: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 35: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 36: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 37: East Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 38: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 39: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 40: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 41: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 42: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 43: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 44: South Asia Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 45: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 46: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 47: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 48: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 49: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 50: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 51: Oceania Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 52: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 53: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 54: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 55: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Immunotherapy Type

Table 56: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 57: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Allergen

Table 58: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Sublingual Allergy Immunotherapy Market Average Drug Pricing 2019, By Product Type ($)

Figure 02: Global Allergy Immunotherapy Market Volume (Mn Units) Analysis, 2015-2019

Figure 03: Global Allergy Immunotherapy Market Volume Forecast (Mn Units), 2020-2030

Figure 04: Global Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 05: Global Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 06: Global Allergy Immunotherapy Market Absolute $ Opportunity, 2020 - 2030

Figure 07: Global Allergy Immunotherapy Market Share Analysis (%), By Product Type, 2020-2030

Figure 08: Global Allergy Immunotherapy Market Y-o-Y Analysis (%), By product Type, 2020-2030

Figure 09: Global Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 10: Global Allergy Immunotherapy Market Share Analysis (%), By Immunotherapy Type, 2020-2030

Figure 11: Global Allergy Immunotherapy Market Y-o-Y Analysis (%), By Immunotherapy Type, 2020-2030

Figure 12: Global Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 13: Global Allergy Immunotherapy Market Share Analysis (%), By Indication, 2020-2030

Figure 14: Global Allergy Immunotherapy Market Y-o-Y Analysis (%), By Indication, 2020-2030

Figure 15: Global Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 16: Global Allergy Immunotherapy Market Share Analysis (%), By Allergen, 2020-2030

Figure 17: Global Allergy Immunotherapy Market Y-o-Y Analysis (%), By Allergen, 2020-2030

Figure 18: Global Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 19: Global Allergy Immunotherapy Market Share Analysis (%), By Distribution channel, 2020-2030

Figure 20: Global Allergy Immunotherapy Market Y-o-Y Analysis (%), By Distribution channel, 2020-2030

Figure 21: Global Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 22: Global Allergy Immunotherapy Market Share Analysis (%), By Region, 2020-2030

Figure 23: Global Allergy Immunotherapy Market Y-o-Y Analysis (%), By Region, 2020-2030

Figure 24: Global Allergy Immunotherapy Market Attractiveness Analysis by Region, 2020-2030

Figure 25: North America Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 26: North America Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 27: North America Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 28: North America Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 29: North America Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 30: North America Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 31: North America Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 32: North America Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 33: North America Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 34: North America Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 35: North America Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 36: North America Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 37: North America Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 38: North America Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 39: Latin America Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 40: Latin America Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 41: Latin America Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 42: Latin America Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 43: Latin America Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 44: Latin America Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 45: Latin America Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 46: Latin America Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 47: Latin America Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 48: Latin America Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 49: Latin America Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 50: Latin America Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 51: Latin America Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 52: Latin America Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 53: Europe Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 54: Europe Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 55: Europe Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 56: Europe Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 57: Europe Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 58: Europe Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 59: Europe Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 60: Europe Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 61: Europe Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 62: Europe Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 63: Europe Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 64: Europe Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 65: Europe Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 66: Europe Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 67: East Asia Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 68: East Asia Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 69: East Asia Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 70: East Asia Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 71: East Asia Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 72: East Asia Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 73: East Asia Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 74: East Asia Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 75: East Asia Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 76: East Asia Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 77: East Asia Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 78: East Asia Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 79: East Asia Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 80: East Asia Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 81: South Asia Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 82: South Asia Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 83: South Asia Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 84: South Asia Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 85: South Asia Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 86: South Asia Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 87: South Asia Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 88: South Asia Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 89: South Asia Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 90: South Asia Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 91: South Asia Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 92: South Asia Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 93: South Asia Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 94: South Asia Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 95: Oceania Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 96: Oceania Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 97: Oceania Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 98: Oceania Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 99: Oceania Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 100: Oceania Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 101: Oceania Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 102: Oceania Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 103: Oceania Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 104: Oceania Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 105: Oceania Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 106: Oceania Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 107: Oceania Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 108: Oceania Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 109: Middle East & Africa Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 110: Middle East & Africa Allergy Immunotherapy Market Value Share, By Immunotherapy, 2020 (E)

Figure 111: Middle East & Africa Allergy Immunotherapy Market Value Share, By Country, 2020 (E)

Figure 112: Middle East & Africa Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 113: Middle East & Africa Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 114: Middle East & Africa Allergy Immunotherapy Market Value Share, By Distribution Channel, 2020 (E)

Figure 115: Middle East & Africa Allergy Immunotherapy Market Value Analysis (US$ Mn), 2015-2019

Figure 116: Middle East & Africa Allergy Immunotherapy Market Value Forecast (US$ Mn), 2020-2030

Figure 117: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis By Product Type, 2020-2030

Figure 118: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis by Immunotherapy Type, 2020-2030

Figure 119: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis by Indication, 2020-2030

Figure 120: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis by Allergen, 2020-2030

Figure 121: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 122: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis by Country, 2020-2030

Figure 123: U. S. Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 124: U. S. Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 125: U. S. Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 126: U. S. Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 127: U. S. Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 128: Canada Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 129: Canada Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 130: Canada Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 131: Canada Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 132: Canada Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 133: Mexico Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 134: Mexico Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 135: Mexico Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 136: Mexico Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 137: Mexico Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 138: Brazil Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 139: Brazil Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 140: Brazil Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 141: Brazil Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 142: Brazil Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 143: Argentina Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 144: Argentina Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 145: Argentina Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 146: Argentina Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 147: Argentina Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 148: U.K. Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 149: U.K. Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 150: U.K. Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 151: U.K. Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 152: U.K. Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 153: Germany Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 154: Germany Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 155: Germany Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 156: Germany Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 157: Germany Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 158: France Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 159: France Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 160: France Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 161: France Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 162: France Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 163: Italy Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 164: Italy Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 165: Italy Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 166: Italy Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 167: Italy Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 168: Spain Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 169: Spain Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 170: Spain Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 171: Spain Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 172: Spain Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 173: Benelux Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 174: Benelux Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 175: Benelux Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 176: Benelux Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 177: Benelux Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 178: Russia Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 179: Russia Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 180: Russia Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 181: Russia Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 182: Russia Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 183: China Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 184: China Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 185: China Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 186: China Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 187: China Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 188: Japan Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 189: Japan Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 190: Japan Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 191: Japan Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 192: Japan Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 193: South Korea Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 194: South Korea Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 195: South Korea Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 196: South Korea Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 197: South Korea Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 198: India Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 199: India Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 200: India Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 205: ASEAN Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 206: ASEAN Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 207: ASEAN Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 208: Australia Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 209: Australia Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 210: Australia Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 211: Australia Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 212: Australia Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 213: New Zealand Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 214: New Zealand Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 215: New Zealand Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 216: New Zealand Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 217: New Zealand Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 218: GCC Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 219: GCC Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 220: GCC Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 221: GCC Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 222: GCC Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Figure 223: Turkey Allergy Immunotherapy Market Value Share, By Product Type, 2020 (E)

Figure 224: Turkey Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 229: South Africa Allergy Immunotherapy Market Value Share, By Immunotherapy Type, 2020 (E)

Figure 230: South Africa Allergy Immunotherapy Market Value Share, By Indication, 2020 (E)

Figure 231: South Africa Allergy Immunotherapy Market Value Share, By Allergen, 2020 (E)

Figure 232: South Africa Allergy Immunotherapy Market Value Share, By Distribution Channel 2020 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Allergy Immunotherapy Market